The effects of chikungunya virus infection on people living with HIV during the 2014 Martinique outbreak.
Mathilde PircherEdwin PitonoSandrine Pierre-FrançoisSabine MolcardLauren Brunier-AgotLaurence FagourFatiha NajioullahRaymond CesaireSylvie AbelLise CuzinAndré CabiéPublished in: PloS one (2020)
Our objective was to describe the clinical presentation of chikungunya virus (CHIKV) infection in patients living with HIV (PLHIV) during the 2014 Martinique outbreak. During the outbreak and the 6 following months, all PLHIV coming in our unit for a medical evaluation answered questions about potential CHIKV related symptoms, and had blood tests to assess the diagnosis. For patients coming in at the acute phase of infection, we are able to provide and analyze CD4+, CD8+ T-cells and HIV viral load evolution before, during and after CHIK infection. Among the 1 003 PLHIV in care in the center at the time of the outbreak, 188 (94 men and 94 women) had confirmed (following the WHO definition) CHIKV infection. Clinical presentation was common in 63% of the cases, severe and atypical forms were scarce. During the acute phase, CD4+ and CD8+ T-cells (evaluated in 30 PLHIV, 15 men and 15 women) absolute numbers dropped significantly, but returned to pre-CHIKV values after the acute phase. Reassuringly, CD4 and CD8 T cells proportions did not decrease during the acute phase. CHIKV infection had no significant impact on this anti-retroviral treated population.
Keyphrases
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- healthcare
- zika virus
- prognostic factors
- peritoneal dialysis
- hiv infected
- palliative care
- hepatitis c virus
- human immunodeficiency virus
- antiretroviral therapy
- patient reported outcomes
- early onset
- hiv positive
- pain management
- drug induced
- nk cells
- aedes aegypti
- dengue virus
- quality improvement
- men who have sex with men
- disease virus